Join us at the Premier Event for the Products Liability and MDL Defense Bar
Network and benchmark on the latest multi-district litigation strategies with 400+ pharmaceutical and device litigators, private practice attorneys and Judges hearing these matters.
What’s NEW for 2024
Interactive Audience Polling
Provide input during these real-world case studies and in-depth strategy discussions with leading industry practitioners.
Case Study to Explore the Capabilities of AI in Analyzing Legal Proceedings
An AI tool and a Law Firm Senior Associate will examine a product liability Complaint and decide next steps for pleadings, client advisement and resolution strategies – audience will vote on the strategies.
The End of Chevron Deference
Leading Supreme Court practitioners will guide a critical discussion on the current and future impact of the Supreme Court’s Loper Bright ruling.
Developing and Implementing Exit Strategies to Conclude Drug and Device Litigation
Addressing best practices for developing and implementing effective exit strategies and identifying common challenges in product liability settlements.
Key Insights from Groundbreaking Rulings
An exploration of the year’s biggest cases based on novel and non-traditional plaintiff theories.
Navigating the New Rule 702 Amendments
Seasoned litigators discussing ways to leverage the amendments and transform how expert testimony is assessed.
2024 Conference Co-Chairs
Christiana Jacxsens
General Counsel, Life Sciences & Litigation
B. Braun Medical Inc.
Danielle Diviaio
ED & Executive Counsel, Litigation
Boehringer Ingelheim
Meagan Thwaites
Senior Legal Director, Global Litigation
Boston Scientific
Renowned Jurists
Honorable Karen K. Caldwell
Chief Judge
U.S. District Court, E.D. Kentucky (Chair, Judicial Panel on Multidistrict Litigation [JPML])
Honorable Brian H. May
Circuit Judge, Division 1
St. Louis County Circuit Court
Honorable John R. Tunheim
Sr. U.S. District Judge
U.S. District Court, District of Minnesota
Featured Speakers
Adam Bassing
Head of Global Litigation
UCB, Inc.
Lisa A. Dunkin
Vice President & Associate General Counsel, Litigation
Zimmer Biomet
Lora Spencer
Senior Global Litigation & Investigations Counsel
Medtronic
Amy Todd Klug
General Counsel and Secretary, Head of Legal and Corporate Affairs
Daiichi Sankyo, Inc.
Jobina Jones-McDonnell
Vice President, Assistant General Counsel, Litigation and Risk
Endo Pharmaceuticals
Richard W. Silbert
Vice President, Legal Strategy & Public Health Initiatives
Purdue Pharma L.P.
Benefit from our Pre-Conference Working Groups
Each working group offers 3.5 hours of dynamic and in-depth discussions on the essential components of effective MDL defense strategies, featuring insights from both in-house and outside counsel perspectives.
Working Groups are offered In-Person only.
Working Group AMastering MDL Defense: Strategic Approaches to Overcome Complex Challenges and Dismiss Meritless Claims
December 2, 2024
9:00 am – 12:30 pm
Working Group BDemystifying and Defeating Junk Science in the Courtroom: Techniques to Identify and Challenge Unreliable Evidence
December 2, 2024
1:30 pm – 5:00 pm
Complimentary Webinar
Implications of the Latest Rulings, Settlements and Evidentiary Amendments to Drug and Medical Device Litigation: A View from In-House Practitioners
Continuing Legal Education Credits
Earn CLE/Ethics Credits
Accreditation will be sought in those jurisdictions requested by the registrants which have continuing education requirements. This course is identified as nontransitional for the purposes of CLE accreditation.
Learn MoreNetwork and Benchmark with Representatives from Leading Drug and Medical Device Companies Including:
- Bayer Corporation
- Beckton Dickinson and Company
- Boehringer Ingelheim
- Bristol Myers Squibb
- Boston Scientific
- Daiichi Sankyo
- Endo Pharmaceuticals
- Genentech
- GlaxoSmithKline
- Johnson & Johnson
- Medtronic
- Nuvasive
- Olympus Corporation
- Purdue Pharma
- Smith & Nephew
- Solventum
- Teleflex Inc.
- UCB Inc.
- Viatris
- WL Gore & Associates Inc.
- Zimmer Biomet
The Premier Event for the Products Liability and MDL Defense Bar!
400+
Attendees
20
Content-Rich
Panel Discussions
70+
Speakers
Including More Than 30 In-House Counsel from Leading Life Sciences Companies
3
Full Days of
Extended Networking
Sponsorship Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
Don’t miss the opportunity to maximize participation or showcase your organizations services and talent. For more information, please contact:
Aaron Goldstein | [email protected]
“There is no better forum for leading edge thinking on today’s most pressing drug and med litigation challenges.”
“Great agenda and networking opportunities.”
“It was good to see a panel of judges that are familiar with the JPML and MDLs, as well as state coordinated proceedings, and who are currently presiding over some of the largest mass torts.”
“ACI’s Drug & Medical Device Conference is THE must attend, premier conference for attorneys practicing in the drug and medical device space.”
“Excellent insight into current trial issues with major litigation of interest; very engaging.”
“I look forward to the ACI Drug and Med Conference every year as I’m sure to find helpful discussion on current topics that matter to me as well as a balanced outlook from both in-house and outside counsel.”
